Strong third quarter results demonstrate continued progress on Savaria One

In This Article:

Savaria Corporation
Savaria Corporation

LAVAL, Québec, Nov. 06, 2024 (GLOBE NEWSWIRE) -- Savaria Corporation (“Savaria”) (TSX: SIS), one of the global leaders in the accessibility industry, is pleased to announce its results for the third quarter of 2024.

Highlights – Q3 2024 compared to Q3 2023

  • Revenue was $213.6M, compared to $210.1M in 2023, an increase of 1.7% mainly due to organic growth of 0.2% and a positive foreign exchange impact of 1.7%, partially offset by the divestitures of Van-Action and Freedom Motors.

    • Accessibility organic growth stood at 0.6%, including growth of 8.0% coming from North America, mostly offset by a contraction of 6.6% from Europe.

    • Patient Care organic revenue contracted by 1.1%.

  • Gross profit was $79.1M, up $6.6M or 9.0%, representing 37.0% of revenue, an increase of 250 bps compared to 34.5% in Q3 2023.

  • Operating income was $22.0M, up $1.4M or 6.9%, representing 10.3% of revenue compared to 9.8% in Q3 2023.

  • Adjusted EBITDA* was $41.7M, up $7.3M or 21.0%, or $0.58 per share, up $0.05, when compared to Q3 2023.

  • Adjusted EBITDA margin* stood at 19.5%, up 310 bps compared to 16.4% in Q3 2023.

    • Accessibility adjusted EBITDA margin reached 21.3%.

    • Patient Care adjusted EBITDA margin stood at 17.4%.

  • Net earnings were $13.0M, or $0.18 per share on a diluted basis, compared to $12.1M or $0.18 per share in Q3 2023.

  • The ratio of net debt to adjusted EBITDA* stood at 1.69 in comparison to 2.07 as at December 31, 2023.

  • Available funds* of $247.2M, as of September 30, 2024, to support working capital, investments and growth opportunities.

 

Q3

YTD

in thousands of dollars, except per-share amounts and percentages

 

2024

 

 

2023

 

Change

 

2024

 

 

2023

 

Change

Revenue

$

213,634

 

$

210,094

 

1.7

%

$

644,422

 

$

620,115

 

3.9

%

Gross profit

$

79,120

 

$

72,560

 

9.0

%

$

237,488

 

$

211,698

 

12.2

%

% of revenue

 

37.0

%

 

34.5

%

250 bps

 

36.9

%

 

34.1

%

280 bps

Operating income

$

22,040

 

$

20,622

 

6.9

%

$

62,365

 

$

52,307

 

19.2

%

Net earnings

$

13,026

 

$

12,054

 

8.1

%

$

35,034

 

$

26,882

 

30.3

%

Diluted net earnings per share

$

0.18

 

$

0.18

 

-

 

$

0.49

 

$

0.41

 

19.5

%

Adjusted net earnings*

$

17,040

 

$

12,698

 

34.2

%

$

46,383

 

$

30,061

 

54.3

%

Adjusted net earnings per share*

$

0.24

 

$

0.19

 

26.3

%

$

0.65

 

$

0.46

 

41.3

%

Adjusted EBITDA*

$

41,737

 

$

34,484

 

21.0

%

$

118,363

 

$

94,970

 

24.6

%

Adjusted EBITDA per share*

$

0.58

 

$

0.53

 

9.4

%

$

1.66

 

$

1.46

 

13.7

%

% of revenue

 

19.5

%

 

16.4

%

310 bps

 

18.4

%

 

15.3

%

310 bps

*Non-IFRS measures are described and reconciled in sections 3, 6 and 8 of the MD&A.